Parameter | + PI (n = 16) | + NNRTI (n = 19) | p | Normal range |
---|---|---|---|---|
Age, y | 42.3 (14.5)* | 39.7 (11.9)* | 0.57 | Â |
Sex ratio (M,%) | 62.5 | 63.2 | 0.96 | Â |
Origin | Â | Â | 0.96 | Â |
  European (%) | 75.0 | 73.7 | ||
  African (%) | 25.0 | 26.3 | ||
Current smokers (%) | 0 | 31.6 | 0.03 | Â |
Duration of diagnosed infection, years | 2.2 (2.9)* | 1.6 (1.8)* | 0.46 | Â |
CDC categories | Â | Â | 0.31 | Â |
  A + B (%) | 81.3 | 94.7 | ||
  C (%) | 18.7 | 5.3 | ||
Viral load (log10/ml) | 5.05 (0.85)* | 5.04 (0.55)* | 0.97 | Â |
CD4 lymphocytes/ml | 240 (153)* | 240 (131)* | 0.90 | Â |
BMI, kg/m2 | 23.8 (3.6)* | 24.0 (3.6)* | 0.84 | Â |
Body Lean Mass, kg | 46.3 (8.8)* | 49.4 (10.3)* | 0.35 | Â |
Body Fat Mass, kg | 18.4 (8.9)* | 19.4 (10.9)* | 0.79 | Â |
Fat Mass ratio | 0.97 | 0.97 | 0.99 | Â |
  In men | 1.05 (0.16)* | 1.03 (0.14)* | 0.81 | ≤ 1.5 |
  In women | 0.85 (0.10)* | 0.87 (0.14)* | 0.74 | ≤ 1.2 |
BMD L2-L4 (g/cm2) | 1.233 | 1.249 | 0.82 | Â |
Cholesterol, g/l | 1.88 (0.45)* | 1.61 (0.34)* | 0.05 | 1.5 – 2.2 |
HDL-cholesterol, g/l | 0.44 (0.08)* | 0.38 (0.10)* | 0.10 | > 0.4 |
Triglycerides, g/l | 1.14 (0.58)* | 0.99 (0.48)* | 0.46 | 0.5 – 1.5 |
Glucose, g/l | 0.84 (0.08)* | 0.83 (0.09)* | 0.79 | 0.72 - .1.05 |
Total alkaline phosphatase, U/l | 168 (37)* | 173 (49)* | 0.73 | 100 – 280 |
Bone alkaline phosphatase, μg/l | 8.1 (3.2)* | 8.3 (2.6)* | 0.88 | 5 – 20 |
β-Cross-laps, μg/l | 353 (186)* | 302 (161)* | 0.39 | 160 – 440 |
25-OH-vitamine D3, μg/l | 20.7 (8.2)* | 19.4 (12.0)* | 0.71 | 22 – 45 |
1,25-di-OH-vitaminne D3, ng/l | 49.1 (18.7)* | 49.3 (18.4)* | 0.97 | 25 – 60 |
Parathormone, ng/l | 34.1 (12.9)* | 35.1 (13.3)* | 0.83 | 10 - 65 |
Cockroft (ml/min) | 83.9 (21.9)* | 102.3 (17.3)* | 0.01 | Â |